| Status | Study |
| Recruiting |
Study Name: Management of Women With an Incomplete Evacuation Condition: Abortion, Missed Date: 2017-05-09 Interventions: Drug: misoprostol It will receive misopristol 800 µg (Misotac 200 µg tablets, SIGMA pharmaceut |
| Not yet recruiting |
Study Name: Vaginal Misoprostol In Management Of First Trimester Missed Abortion. Condition: Abortion, Missed Date: 2017-05-08 Interventions: Drug: vaginal misoprostol (800 |
| Not yet recruiting |
Study Name: Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion Condition: Recurrent Miscarriage Date: 2017-04-16 Interventions: Drug: Intralipid Adose of intralipid given and rechecking NKcells activity |
| Recruiting |
Study Name: Use of Pessary in Case of Cervical Insufficiency and Short Cervix Condition: Preterm Labor Date: 2017-03-25 Interventions: Device: cervical pessary Silicone rings known as arabin pessary are used to support the cervix in women |
| Recruiting |
Study Name: Operative Hysteroscopy and Ultrasound Guided Vacuum Aspiration Versus Blind Vacuum Aspiration for the Treatment of Missed Abortion Condition: Missed Abortion Date: 2017-03-10 Interventions: Device: hystroscopy The uterin |
| Recruiting |
Study Name: A Preliminary Study About Recurrent Spontaneous Abortion and Repeated Implantation Failure IVF-ET Patients Treated by Active Immunotherapy With Small Amount of Lymphocytes Condition: Unexplained Recurrent Spontaneous Abortion Date: 2017-03-08 Interventions: Procedure: URSA patients treated by active immunotherapy with small amount of lymphocytes. |
| Not yet recruiting |
Study Name: Cerclage for Twins With Short Cervix Condition: Preterm Birth Preterm Labor With Preterm Delivery, Unspecified Trimester, Fetus 2 Date: 2017-03-03 Interventions: Procedure: Cervical Cerclage placement |
| Enrolling by invitation |
Study Name: Recurrent Pregnancy Loss and Thyroid Disease Condition: Recurrent Pregnancy Loss Date: 2017-02-27 Interventions: Drug: Levothyroxine Levothyroxine is an orodispersible tablet.For the LT4 treatment group, 50μg LT4 |
| Not yet recruiting |
Study Name: AntiPhospholipid Syndrome Low-molecular-weight Heparin Pregnancy Loss Evaluation: The Pilot Study Condition: Antiphospholipid Syndrome in Pregnancy Pregnancy Loss Date: 2017-02-21 Interventions: Drug: Aspirin 81 mg Aspirin 81 |
| Recruiting |
Study Name: JZ Thickness as a Predictor of Recurrent Unexplained First Trimesteric Pregnancy Loss. Condition: Patients With Recurrent Unexplained Pregnancy Loss Date: 2017-02-11 Interventions: Other: Pelvic ultrasound both two dimensional and three dimentional |